Guizhou Zhongyida Co Ltd (900906) - Total Liabilities

Latest as of March 2026: $908.87 Million USD

Based on the latest financial reports, Guizhou Zhongyida Co Ltd (900906) has total liabilities worth $908.87 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Guizhou Zhongyida Co Ltd (900906) equity growth momentum to track the company's year-over-year net asset growth rate.

Guizhou Zhongyida Co Ltd - Total Liabilities Trend (2015–2025)

This chart illustrates how Guizhou Zhongyida Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See 900906 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Guizhou Zhongyida Co Ltd Competitors by Total Liabilities

The table below lists competitors of Guizhou Zhongyida Co Ltd ranked by their total liabilities.

Company Country Total Liabilities
Freeman Gold Corp
V:FMAN
Canada CA$1.40 Million
Noble Development Public Company Limited
BK:NOBLE
Thailand ฿18.54 Billion
Sena Development Public Company Limited
BK:SENA
Thailand ฿24.54 Billion
TOPTEC Co. Ltd
KQ:108230
Korea ₩167.76 Billion
Nanoform Finland Plc
HE:NANOFH
Finland €12.56 Million
Thai Rung Union Car Public Company Limited
BK:TRU
Thailand ฿442.46 Million
Kpx Green Chem
KO:083420
Korea ₩80.47 Billion
Empery Digital Inc.
NASDAQ:EMPD
USA $51.74 Million

Liability Composition Analysis (2015–2025)

This chart breaks down Guizhou Zhongyida Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Guizhou Zhongyida Co Ltd market cap and net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 0.53 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 6.54 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.87 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Guizhou Zhongyida Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Guizhou Zhongyida Co Ltd (2015–2025)

The table below shows the annual total liabilities of Guizhou Zhongyida Co Ltd from 2015 to 2025.

Year Total Liabilities Change
2025-12-31 $892.42 Million -5.97%
2024-12-31 $949.07 Million -12.23%
2023-12-31 $1.08 Billion -5.47%
2022-12-31 $1.14 Billion -7.01%
2021-12-31 $1.23 Billion -5.71%
2020-12-31 $1.30 Billion +8.17%
2019-12-31 $1.21 Billion +146.80%
2018-12-31 $488.71 Million +23.26%
2017-12-31 $396.49 Million -33.80%
2016-12-31 $598.89 Million +621.70%
2015-12-31 $82.98 Million --

About Guizhou Zhongyida Co Ltd

SHG:900906 China Chemicals
Market Cap
$78.92 Million
Market Cap Rank
#20113 Global
#4680 in China
Share Price
$0.22
Change (1 day)
-0.45%
52-Week Range
$0.21 - $0.39
All Time High
$0.84
About

Guizhou Zhongyida Co., Ltd produces and sells fine chemical products in the People's Republic of China. The company offers pentaerythritol series products such as, industrial pentaerythritol, dipentaerythritol, and tripentaerythritol; and trimethylolpropane series products consisting, industrial ditrimethylolpropane and trimethylolpropane, edible alcohol, as well as main and by-product DDGS feed,… Read more